Debevoise Nominated in 13 Categories in 2021 Deal Awards

29 July 2021

Debevoise has been nominated in 13 categories in The Deal’s annual Deal Awards spanning the large cap and middle market groups. Winners will be announced on September 21. At last year’s Deal Awards, Debevoise partner Sue Meng was honored for TMT Dealmaker of the Year and the firm was honored for Healthcare Deal of the Year.

Large Cap Categories

  • TMT Dealmaker of the Year: Michael Diz
  • PE Dealmaker of the Year: Paul Bird
  • Financial Services Dealmaker: Nicholas Potter
  • Deal of the Year: IFF adds DuPont Nutrition & Biosciences in Reverse Morris Trust
  • Most Innovative Deal of the Year: Liberty Broadband acquires GCI Liberty
  • Most Innovative deal of the Year: CD&R carves out HD Supply White Cap, adds Construction Supply
  • PE Deal of the Year: Morgan Stanley Capital sells Pathway Vet to TSG
  • Cross-border Deal of the Year: Novartis acquires Medicines Co
  • Energy and Industrials Deal: IFF adds DuPont Nutrition & Biosciences
  • Energy & Industrials Deal: CD&R carves out HD Supply White Cap, adds Construction Supply
  • TMT Deal of the Year: Marvell acquires fellow chipmaker Inphi

Middle Market Categories

  • Most Innovative Deal: Gogo sells commercial aviation Wi-Fi business to Intelstat
  • Healthcare, Pharma & Biotech Law Firm: Debevoise & Plimpton LLP

The Deal Awards celebrate the exceptional advisors and service providers who power the deal economy. Winners were selected through an intensive three-step judging process, beginning with hundreds of peer nominations. The newsroom then determined a shortlist of applicants based off of in-depth interviews with leading analysts in the field, uncovering the most significant deals and dealmakers of the year. Final awardees were determined via majority vote by the publication’s top editors.